| Literature DB >> 28630851 |
Maya Kale1, Pravin Padalkar2, Varshil Mehta3.
Abstract
INTRODUCTION: Post-operative wound infections after spinal surgery is a very serious problem, leading to a risk of significant morbidity which may even lead to prolonged hospitalization. Various treatment protocols have been recommended for debridement, antibiotic, and soft-tissue management, but with mixed results. However, the risk of morbidity is still high with these treatment options. Vacuum-assisted closure (VAC) system has been gaining popularity recently in the management of subacute, acute, and chronic wounds. This study aims to review the use of the indigenous VAC in the management of deep infections after spinal instrumentation surgery. CASE SERIES: Between 2010 and 2015, 12 out of 514 patients who developed a deep infection after spinal surgery, were selected and reviewed retrospectively at multiple centers (MGM Hospital, Kamothe and Center for Orthopaedic & Spine Surgery, New Panvel, Navi Mumbai, India). Out of 12 patients, one of the patients needed a partial implant exchange although none of the cases needed complete implant removal. All patients had achieved clean closed wounds along with a retention of the instrumentation. There was no need for flap surgery to cover wound defect in any case. However, antibiotic treatment was necessary in all cases. None of the patients showed a new infection after the treatment.Entities:
Keywords: Spinal infection; vacuum-assisted closure; wound closure
Year: 2017 PMID: 28630851 PMCID: PMC5458710 DOI: 10.13107/jocr.2250-0685.706
Source DB: PubMed Journal: J Orthop Case Rep ISSN: 2250-0685
Figure 1Wound vacuum-assisted closure system (Triage Meditech).
Figure 2Vacuum-assisted closure system generated negative pressure helping in closure.
Wound management with VAC in postoperative infections
| Case No. | Sex/Age (years) | Diagnosis | Initial procedure | Organism isolated | Postoperative day of infection | VAC duration days | Number of VAC changes and number of debridement | Initial IV antibiotic therapy (after culture and sensitivity) | Oral antibiotic therapy | Duration of IV antibiotic therapy (weeks) | Duration of oral antibiotic therapy (weeks) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M/55 | Spinal stenosis | TLIF+posterior fusion | MRSA | 14 | 9 | 2 | Cefuroxime linezolid | Linezolid | 1 | 2 |
| 2 | M/38 | Spondylolisthesis | TLIF posterior fusion | 14 | 5 | 1 | Cefuroxime moxifloxacin | Linezolid moxifloxacin | 1 | 2 | |
| 3 | M/45 | Khyphosis/ank spond | PSO with posterior instrumentation | 14 | 21 | 3 | Meropenem | Linezolid | 2 | 2 | |
| 4 | F/13 | Congenital scoliosis | VCR with posterior fusion | 14 | 7 | 2 | Imipenem | Linezolid | 1 | 2 | |
| 5 | M/55 | L1 chance fracture | Posterior fixation | MRSA | 14 | 14 | 2 | Meropenem | Linezolid | 1 | 2 |
| 6 | M/50 | PID with instability | TLIF posterior fusion | 7 | 7 | 1 | Cefuroxime | Rifampicin | 1 | 2 | |
| 7 | M/70 | Koch’s spine | Posterior instrumentation | 10 | 7 | 1 | Linezolid | Rifampicin Linezolid | 1 | 3 | |
| 8 | M/55 | Pid with instability | TLIF+posterior fusion | 7 | 7 | 1 | Meropenem | Ferropenam | 1 | 2 | |
| 9 | F/49 | Spondylolisthesis | TLIF+posterior fusion | MRSA | 9 | 12 | 1 | Pipracillin linezolid | Linezolid | 2 | 6 |
| 10 | F/60 | Koch’s spine | Posterior decompression and fusion | MRSA | 19 | 12 | 4 | Ampicillin/sulbactam | Teicoplanin | 7 | 5 |
| 11 | F/54 | Koch’s spine | Posterior decompression and fusion | MRSA | 15 | 21 | 3 | Meropenem | Rifampicin | 2 | 6 |
| 12 | F/51 | D12 brust fracture spine | Posterior pedicular screw fixation | 45 | 24 | 4 | Meropenem | Rifampicin, ferropenam | 2 | 3 |
IV: Intravenous, MRSA: Methicillinresistant Staphylococcus aureus, TLIF: Transforaminal lumbar interbody fusion, VAC: Vacuumassisted closure. Initial antibiotic therapy before culture and sensitivity was cefuroxime and amikacin. E. coli: Escherichia coli
Figure 3Serial images of post-operative wound treated with vacuum-assisted closure.